We are live on ! Find out more
PAHC icon

Phibro Animal Health

176 hedge funds and large institutions have $674M invested in Phibro Animal Health in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 85 increasing their positions, 57 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 57

4% more capital invested

Capital invested by funds: $651M → $674M (+$23.4M)

0.6% more ownership

Funds ownership: 100.19%100.78% (+0.6%)

8% less funds holding

Funds holding: 191176 (-15)

52% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 27

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
176
Holders Change
-15
Holders Change %
-7.85%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
85
Reduced
57
Closed
27
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$112M -$175K -5,639 -0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$72.4M +$1.58M +50,809 +2%
CVA
3
Ceredex Value Advisors
Florida
$29.3M +$1.52M +48,694 +6%
Renaissance Technologies
4
Renaissance Technologies
New York
$25.7M -$1.61M -51,800 -6%
FIM
5
Foresters Investment Management
New York
$21.7M +$1.72M +55,353 +9%
State Street
6
State Street
Massachusetts
$21.1M +$85K +2,732 +0.4%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$20.2M -$122K -3,918 -0.6%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$17.9M +$359K +11,535 +2%
Goldman Sachs
9
Goldman Sachs
New York
$16.5M +$1.43M +45,881 +10%
SBH
10
Segall Bryant & Hamill
Illinois
$16.2M -$890K -28,601 -6%
Northern Trust
11
Northern Trust
Illinois
$13M -$1.86M -59,901 -13%
TA
12
Teachers Advisors
New York
$12.4M +$18.4K +591 +0.2%
Ameriprise
13
Ameriprise
Minnesota
$11.6M -$531K -17,074 -5%
Fuller & Thaler Asset Management
14
Fuller & Thaler Asset Management
California
$11.3M -$1.23M -39,631 -10%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$11.1M +$4.76M +152,853 +83%
EAM
16
Eagle Asset Management
Florida
$10.9M -$404K -12,970 -4%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$10.7M -$1.07M -34,231 -10%
JP Morgan Chase
18
JP Morgan Chase
New York
$9.95M +$115K +3,691 +1%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$9.76M -$908K -29,170 -9%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$9.11M +$858K +27,572 +11%
Wells Fargo
21
Wells Fargo
California
$8.32M +$3.15M +101,282 +67%
FMI
22
Fiduciary Management Inc
Wisconsin
$8.19M +$7.73M +248,300 New
TCIM
23
TIAA CREF Investment Management
New York
$7.89M +$8.43K +271 +0.1%
Janus Henderson Group
24
Janus Henderson Group
United Kingdom
$7.6M +$6.82M +219,165 +1,961%
Morgan Stanley
25
Morgan Stanley
New York
$7.49M +$3.22M +103,345 +84%

PAHC Hedge Fund Activity: Q1 2019 in Review

176 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2019, worth a combined $674M — up 3.6% from $651M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of PAHC and 13 opened new positions — a net loss of 14 holders — while 57 trimmed existing stakes and 85 added.

The largest buyer was Fiduciary Management Inc, opening a new position worth an estimated $7.73M. The largest seller was Invesco, cutting an estimated $17.6M.

  • 176 institutional investors held Phibro Animal Health (PAHC) as of Q1 2019, down from 191 in Q4 2018.
  • Funds reported $674M of Phibro Animal Health stock for Q1 2019, up 3.6% quarter-over-quarter.
  • 13 funds opened new Phibro Animal Health positions in Q1 2019 and 27 closed out, a net change of -14 holders.
  • The largest Phibro Animal Health buyer in Q1 2019 was Fiduciary Management Inc, an estimated $7.73M added.
  • The largest Phibro Animal Health seller in Q1 2019 was Invesco, an estimated $17.6M sold.

Based on aggregated 13F filings for Q1 2019.